STOCK TITAN

Kura Oncology officer proposes $71.5K stock sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) officer Brian Powl reported a proposed sale of 9,196 shares of common stock, with an aggregate market value of 71,452.92 and an approximate sale date of November 16, 2026. The shares were acquired from the issuer as restricted stock units on November 13, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice also lists four sales in the prior three months.

Proposed sale 9,196 shares Common stock; approximate sale date November 16, 2026
Aggregate market value 71,452.92 Proposed sale of 9,196 common shares
Shares outstanding 92,784,785 shares Reported in the securities information
RSU financial
"shares acquired from the issuer as RSU"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
Restricted Stock Units financial
"prior sales listed as Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 Sales regulatory
"prior sales labeled 10b5-1 Sales"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Sell-to cover financial
"the September 28 transaction labeled Sell-to cover"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KURA shares did Brian Powl report for sale?

Brian Powl reported a proposed sale of 9,196 common shares, with an aggregate market value of 71,452.92. The approximate sale date is November 16, 2026.

What prior KURA stock sales are listed for Brian Powl?

The prior-sales table lists 4,345 restricted stock units on August 21, 2026, for gross proceeds of 51,663.26; 8,000 on September 28, 2026, for 84,497.61; 9,020 in a Sell-to cover transaction on September 28, for 94,685.65; and 15,430 on September 29, for 165,853.11. The other three entries are labeled 10b5-1 Sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading